Your browser is no longer supported. Please, upgrade your browser.
Settings
ESPR Esperion Therapeutics, Inc. daily Stock Chart
ESPR [NASD]
Esperion Therapeutics, Inc.
Index- P/E- EPS (ttm)-6.96 Insider Own13.50% Shs Outstand26.08M Perf Week-3.88%
Market Cap1.10B Forward P/E- EPS next Y-5.33 Insider Trans12.43% Shs Float21.36M Perf Month2.06%
Income-172.60M PEG- EPS next Q-1.72 Inst Own- Short Float31.84% Perf Quarter-43.40%
Sales- P/S- EPS this Y-109.80% Inst Trans11.77% Short Ratio4.88 Perf Half Y-42.45%
Book/sh8.05 P/B5.24 EPS next Y17.00% ROA-67.70% Target Price72.23 Perf Year-13.52%
Cash/sh7.56 P/C5.58 EPS next 5Y26.60% ROE-77.50% 52W Range33.06 - 82.68 Perf YTD-35.97%
Dividend- P/FCF- EPS past 5Y28.10% ROI- 52W High-49.01% Beta2.25
Dividend %- Quick Ratio6.70 Sales past 5Y- Gross Margin- 52W Low27.53% ATR2.59
Employees57 Current Ratio6.70 Sales Q/Q- Oper. Margin- RSI (14)53.31 Volatility6.70% 6.92%
OptionableYes Debt/Eq0.00 EPS Q/Q3.50% Profit Margin- Rel Volume0.46 Prev Close42.16
ShortableYes LT Debt/Eq0.00 EarningsAug 07 BMO Payout- Avg Volume1.39M Price42.16
Recom2.50 SMA203.05% SMA505.02% SMA200-27.51% Volume0 Change0.00%
Jul-11-18Downgrade Northland Capital Outperform → Market Perform
May-03-18Downgrade JP Morgan Neutral → Underweight $41
May-02-18Downgrade BofA/Merrill Buy → Underperform
Mar-27-18Reiterated Chardan Capital Markets Neutral $75 → $100
Feb-21-18Reiterated Needham Strong Buy $81 → $94
Jan-22-18Downgrade Citigroup Buy → Neutral
Jan-18-18Initiated Credit Suisse Outperform $103
Jan-17-18Reiterated UBS Buy $62 → $88
Jan-05-18Upgrade BofA/Merrill Neutral → Buy
Dec-14-17Upgrade Needham Buy → Strong Buy $72 → $81
Dec-06-17Reiterated Chardan Capital Markets Neutral $20 → $75
Aug-29-17Initiated Northland Capital Outperform $72
Aug-11-17Resumed BofA/Merrill Neutral
Aug-09-17Upgrade Jefferies Hold → Buy
Jul-11-17Initiated Jefferies Hold
Jun-27-17Reiterated Stifel Buy $45 → $60
Jun-23-17Initiated Deutsche Bank Buy $48
Mar-30-17Upgrade UBS Neutral → Buy $23 → $52
Mar-20-17Upgrade Credit Suisse Underperform → Neutral
Feb-28-17Upgrade Citigroup Neutral → Buy
Jul-16-18 07:45AM  Insider Buys Of The Week: Energen, Esperion Therapeutics And International Flavors Benzinga
Jul-10-18 08:55AM  Options Traders Expect Huge Moves in Esperion Therapeutics (ESPR) Stock Zacks -5.27%
Jul-06-18 10:51AM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ESPR, ORA, MFGP, FLR, and REPH GlobeNewswire
Jul-05-18 05:23PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm GlobeNewswire
04:35PM  DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
02:00PM  CLASS ACTION UPDATE for ESPR, SYMC, and PPG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:00AM  24 HOUR DEADLINE NOTICE: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Immediately Contact the Firm Business Wire
Jul-03-18 02:40PM  FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire +7.78%
08:30AM  Esperion to Host Analyst and Investor Day Event on July 10 GlobeNewswire
Jul-02-18 04:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR ACCESSWIRE
04:16PM  DEADLINE REMINDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
01:22PM  Beaten-down biotech stocks Gilead, Esperion are ready for a bounce MarketWatch
01:03PM  SHAREHOLDER ALERT LC ESPR INWK FLEX KLIC SYMC MFGP FLR REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
09:20AM  KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline Reminder for Esperion Therapeutics, Inc. Investors - ESPR ACCESSWIRE
08:00AM  FINAL DEADLINE NOTICE: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Immediately Contact the Firm GlobeNewswire
Jun-30-18 11:00AM  FINAL DEADLINE ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Immediately Contact the Firm ACCESSWIRE
09:28AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR ACCESSWIRE
Jun-29-18 01:58PM  CLASS ACTION UPDATE for ESPR, PPG and PCG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:30PM  DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jun-28-18 06:38PM  KESSLER TOPAZ MELTZER & CHECK, LLP: Important Deadline Reminder for Esperion Therapeutics, Inc. Investors ACCESSWIRE
04:46PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LC, ESPR, and MFGP GlobeNewswire
02:40PM  IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:34AM  SHAREHOLDER ALERT MOH ESPR PPG ANW QCOM UNM COOL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jun-27-18 01:30PM  INVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:30PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of INWK, ESPR, PRTA, and PPG GlobeNewswire
Jun-26-18 02:30PM  IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:54PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 ESPR GlobeNewswire
Jun-25-18 12:10PM  ESPR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR ACCESSWIRE
Jun-24-18 02:00PM  SHAREHOLDER ALERT: ALGT ESPR FLEX PPG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jun-23-18 08:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ESPR GlobeNewswire
Jun-22-18 03:30PM  IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:00PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR ACCESSWIRE
Jun-21-18 04:09PM  ESPR NOTICE: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important Upcoming Deadline in Class Action ESPR GlobeNewswire -8.86%
01:50PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR ACCESSWIRE
07:25AM  Stock Performance Review on Exelixis and Three Other Biotech Stocks ACCESSWIRE
Jun-20-18 06:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR ACCESSWIRE
04:34PM  Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. on Behalf of Investors ACCESSWIRE
Jun-19-18 04:00PM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Molina Healthcare, Inc., Esperion Therapeutics, Inc., PPG Industries, Inc., Prothena Corporation, and Fluor Corporation GlobeNewswire
10:00AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018 GlobeNewswire
Jun-18-18 05:13PM  The Klein Law Firm Reminds Investors of Class Actions Commenced on Behalf of Shareholders of Molina Healthcare, Inc., Esperion Therapeutics, Inc., Kulicke and Soffa Industries, Inc., and PPG Industries, Inc. GlobeNewswire
04:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm ACCESSWIRE
Jun-16-18 08:10AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ESPR Business Wire
Jun-15-18 04:40PM  ESPR NOTICE: Pawar Reminds of Important July 6, 2018 Lead Plaintiff Deadline in Esperion Therapeutics, Inc. Class Action - ESPR ACCESSWIRE
Jun-14-18 12:09PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 ESPR GlobeNewswire
09:07AM  Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Esperion Therapeutics, Inc. Investors ESPR GlobeNewswire
Jun-13-18 06:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR ACCESSWIRE
11:16AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR ACCESSWIRE
10:14AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018 ACCESSWIRE
09:52AM  ESPR NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR ACCESSWIRE
Jun-12-18 04:01PM  Esperion Announces Late-Breaking Oral Presentation of Full Study 4 Results (1002-048) at the International Symposium on Atherosclerosis GlobeNewswire
Jun-11-18 03:07PM  The Klein Law Firm Reminds Investors of a Class Action on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR) GlobeNewswire
09:54AM  ESPR WIRE NOTICE: Rosen Law Firm Announces Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR PR Newswire
Jun-09-18 10:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ESPR ACCESSWIRE
Jun-08-18 03:42PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR ACCESSWIRE
Jun-07-18 04:45PM  INVESTOR DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:00PM  INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. - ESPR ACCESSWIRE
03:00PM  ESPR EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018 GlobeNewswire
10:47AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018 ACCESSWIRE
Jun-06-18 04:33PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ESPR Business Wire
04:30PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:00PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 ESPR GlobeNewswire
Jun-05-18 05:51PM  Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury Systems, Inc., Ormat Technologies, Inc., and Prothena Corporation PLC PR Newswire
05:32PM  The Klein Law Firm Notifies Investors of a Class Action Commenced on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR) ACCESSWIRE
11:10AM  Esperion Therapeutics, Inc. Reminder: Pawar Law Reminds of Important July 6, 2018 Lead Plaintiff Deadline in Class Action- ESPR ACCESSWIRE
Jun-04-18 03:14PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR ACCESSWIRE
12:17PM  INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed against Esperion Therapeutics, Inc. Business Wire
Jun-01-18 06:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ESPR ACCESSWIRE
03:22PM  ESPR INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018 ACCESSWIRE
08:25AM  New Research Coverage Highlights Esperion Therapeutics, Magna International, Spectra Energy Partners, LP, Toronto Dominion Bank, Flex, and Yirendai Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
May-31-18 03:31PM  ESPR NEWS ALERT: Rosen Law Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. ESPR GlobeNewswire
03:08PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR ACCESSWIRE
11:55AM  WeissLaw LLP: Esperion Therapeutics, Inc. is the Subject of a Legal Investigation PR Newswire
10:50AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline: July 6, 2018 ACCESSWIRE
May-30-18 09:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR ACCESSWIRE
04:00PM  Kessler Topaz Meltzer & Check, LLP Reminds Esperion Therapeutics, Inc. Investors of Important Deadline in Class Action Lawsuit ACCESSWIRE
03:15PM  The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR) Business Wire
09:00AM  Esperion to Participate in Fireside Chat at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-29-18 05:10PM  ESPR ALERT: Pawar Law Reminds of Important July 6, 2018 Lead Plaintiff Deadline in Class Action- ESPR ACCESSWIRE
09:00AM  Esperion Announces the Appointment of Jay P. Shepard to Board of Directors GlobeNewswire
May-27-18 02:00PM  ESPR EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018 Business Wire
May-26-18 11:30AM  DEADLINE NOTICE: Shareholder Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. ESPR ACCESSWIRE
07:15AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR ACCESSWIRE
May-25-18 04:30PM  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
01:39PM  INVESTOR ALERT: Kirby McInerney LLP Advises Esperion Therapeutics, Inc. (ESPR) Investors of Potential Claims Business Wire
11:49AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 Business Wire
10:25AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018 ACCESSWIRE
May-24-18 03:16PM  The Klein Law Firm Announces a Class Action Commenced on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR) Business Wire
11:00AM  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder For Esperion Therapeutics, Inc. Investors GlobeNewswire
May-23-18 04:01PM  The Klein Law Firm Announces a Class Action Filed on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR) GlobeNewswire
03:17PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ESPR GlobeNewswire
11:11AM  Esperion's Top Holder Buys $5.2 Million More in Stock Barrons.com
10:53AM  Merck Wins Again; Esperion In Increments; Gilead As A Talent Farm Forbes
09:16AM  Esperion's cholesterol drug safe, effective in new late-stage study Reuters
08:39AM  Esperion shares halted on late-stage trial results MarketWatch
08:15AM  Esperion Announces Third Pivotal Phase 3 Study of Bempedoic Acid Meets Primary Endpoint GlobeNewswire
May-22-18 03:15PM  ESPR INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018 Business Wire
09:18AM  Kessler Topaz Meltzer & Check, LLP Announces Investor Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. Business Wire
08:00AM  Esperion to Participate in Fireside Chat at the UBS Global Healthcare Conference GlobeNewswire
May-19-18 07:45AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ESPR ACCESSWIRE
May-18-18 03:00PM  ESPR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018 GlobeNewswire
Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its lead product candidate is bempedoic acid/ezetimibe combination pill, a non-statin, orally available, LDL-C lowering therapy for patients with hypercholesterolemia and with atherosclerotic cardiovascular disease, and/or heterozygous familial hypercholesterolemia that is in Phase III long-term safety and tolerability study. Esperion Therapeutics, Inc. was founded in 2008 and is headquartered in Ann Arbor, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BIOTECH TARGET N V10% OwnerJul 12Buy41.7750,0002,088,3003,232,964Jul 13 11:45 AM
BIOTECH TARGET N V10% OwnerJun 29Buy39.4850,0001,973,8053,182,964Jul 03 11:55 AM
BIOTECH TARGET N V10% OwnerJun 21Buy38.5760,0002,314,2243,132,964Jun 25 12:43 PM
BIOTECH TARGET N V10% OwnerJun 07Buy37.7960,0002,267,2923,072,964Jun 11 02:59 PM
GOLDSTEIN DOV A MDDirectorJun 06Option Exercise16.4713,000214,10013,047Jun 08 05:08 PM
BIOTECH TARGET N V10% OwnerJun 05Buy38.4760,0002,308,4403,012,964Jun 07 02:34 PM
BIOTECH TARGET N V10% OwnerMay 21Buy38.7780,0003,101,7602,952,964May 22 03:49 PM
BIOTECH TARGET N V10% OwnerMay 18Buy42.2450,0002,112,0102,872,964May 22 03:49 PM
NEWTON ROGER SDirectorMar 29Sale73.269,044662,563639,682Mar 29 07:47 PM
NEWTON ROGER SDirectorFeb 07Option Exercise6.9934,651242,210652,334Feb 09 05:47 PM
MAYLEBEN TIMOTHY MPresident & CEOJan 31Option Exercise1.174,5495,32546,163Feb 01 05:29 PM
VITULLO NICOLEDirectorJan 25Sale71.7911,674838,07615,329Jan 26 05:24 PM
VITULLO NICOLEDirectorJan 24Option Exercise6.9971,235497,9331,107,894Jan 26 05:24 PM
JANNEY DANIELDirectorJan 18Option Exercise6.9971,237497,947631,204Jan 22 08:49 PM
Bartram RichardChief Financial OfficerJan 02Option Exercise3.7017,89266,20019,092Jan 03 06:01 PM
GOLDSTEIN DOV A MDDirectorDec 18Option Exercise3.7021,47179,44321,518Dec 20 05:53 PM
VITULLO NICOLEDirectorDec 06Sale53.859,326502,20525,927Dec 08 04:14 PM